FDA Clears First Fully Automated Calprotectin Test for IBD Diagnosis, Inova Says

The U.S. Food and Drug Administration (FDA) has approved the QUANTA Flash Calprotectin test to help diagnose inflammatory bowel disease (IBD) and differentiate that disease from irritable bowel syndrome (IBS). Developed by Inova Diagnostics, QUANTA Flash Calprotectin is the first fully automated, random access calprotectin assay given FDA approval. The test is an immunoassay designed to detect